Lv2
138 积分 2024-06-20 加入
Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
1个月前
已完结
Utility of non-invasive liver fibrosis markers to predict the incidence of chronic kidney disease (CKD): A systematic review, meta-analysis, and meta-regression
1个月前
已完结
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
1个月前
已完结
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
1个月前
已完结
Liver Fibrosis and Sudden Cardiac Arrest: A Prospective Cohort Study of 452,454 Individuals
1个月前
已关闭
FIB-4, a surrogate marker of liver fibrosis, predicts mortality and adverse events after acute myocardial ınfarction
1个月前
已完结
Liver fibrosis scores predict liver disease mortality in the United States population
1个月前
已完结
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people
1个月前
已完结
Liver fibrosis scores predict liver disease mortality in the United States population
1个月前
已完结
Global Burden of Cardiovascular Diseases and its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021
1个月前
已完结
皖公网安备34019202002308
